Average FDA approved orphan drug sales U.S. 5 years after launch 2014
This statistic displays the average orphan and non-orphan drug sales in the United States five years after launch in 2014. Average sales for the top 10 orphan drugs approved in 2014 are expected to be 1.33 billion U.S. dollars five years after launch. Orphan drugs are used to target rare diseases or disorders, which in the United States is defined as less than 200,000 patients. The development of orphan drugs are currently incentivized in the United States through the Orphan Drug Act of 1983.
